All news

INmune Bio prices $4.50 million stock and warrant offering

Alpha Vantage · The Manila Times · · AI-summarised by FinFlash

INmune Bio (NASDAQ: INMB) has agreed to a registered direct offering of 3,000,000 common shares alongside a concurrent private placement of warrants for up to 3,000,000 shares, raising roughly $4.50 million. The warrants carry a

Read original source

INMB company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.